9/25/26 13:35 | 9/23/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Monges Viviane | MA | D | | 2 | M.d | 492 | 20.55 | 0 | 24 | | 6 | D | | | | | | | | | | | | | | |
9/25/26 13:35 | 9/23/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Monges Viviane | MA | D | | 2 | S.d | -492 | 20.55 | 0 | -24 | | 6 | D | | | | | | | | | | | | | | |
9/24/26 16:03 | 9/22/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Lu Peng | MA | O | P | 7 | M.d | 5,166 | 16.92 | 0 | 305 | | 110 | D | | | | | | | | | | | | | | |
9/24/26 10:43 | 9/22/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Schikan Johannes Gerardus Christiaan Petrus | MA | D | | 3 | M.d | 7,045 | 34.95 | 0 | 202 | | 115 | D | | | | | | | | | | | | | | |
9/24/26 10:43 | 9/22/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Schikan Johannes Gerardus Christiaan Petrus | MA | D | | 3 | S.d | -7,045 | 34.95 | 0 | -202 | | 115 | D | | | | | | | | | | | | | | |
9/23/26 10:06 | 9/21/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Nassif David W. | MA | O | CFO , CL | 1 | S | -219 | 36.47 | 0 | -6 | | 114 | D | | | | | | | | | | | | | | |
9/21/26 15:20 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Bjork Elisabeth | MA | D | | 2 | M.d | 2,811 | 26.77 | 0 | 105 | | 15 | D | | | | | | | | | | | | | | |
9/21/26 15:20 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Bjork Elisabeth | MA | D | | 2 | S.d | -2,811 | 26.77 | 0 | -105 | | 15 | D | | | | | | | | | | | | | | |
9/21/26 15:16 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Glassman Robert | MA | D | | 6 | M.d | 1,807 | 29.00 | 0 | 62 | | 11 | D | | | | | | | | | | | | | | |
9/21/26 15:16 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Glassman Robert | MA | D | | 6 | S.d | -1,807 | 29.00 | 0 | -62 | | 11 | D | | | | | | | | | | | | | | |
9/21/26 15:13 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Lesage Anne | MA | O | Chief Ea | 3 | S.d | -2,156 | 26.95 | 0 | -80 | | 130 | I | | | | | | | | | | | | | | |
9/21/26 15:10 | 9/17/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Modig Berndt | MA | DO | CEO | 4 | M | 10,750 | 35.03 | 0 | 307 | 31 | 1,300 | I | | | | | | | | | | | | | | |
9/17/26 13:22 | 9/15/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Abele Stefan Andreas | MA | O | Chief Te | 2 | M.d | 2,509 | 27.45 | 0 | 91 | | 39 | D | | | | | | | | | | | | | | |
9/17/26 13:22 | 9/15/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Abele Stefan Andreas | MA | O | Chief Te | 2 | S.d | -2,509 | 27.45 | 0 | -91 | | 39 | D | | | | | | | | | | | | | | |
9/16/26 14:07 | 9/14/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Souverijns Wim | MA | O | Chief Co | 2 | M.dm | 1,372 | 29.77 | 0 | 46 | | 39 | D | | | | | | | | | | | | | | |
9/16/26 14:07 | 9/14/26 | PHVS | Health | Drug | Pharmaceutical Preparations | Souverijns Wim | MA | O | Chief Co | 2 | S.dm | -1,372 | 29.77 | 0 | -46 | | 39 | D | | | | | | | | | | | | | | |